secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001570562-25-000074
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus Q1 revenue $68.5M (+15.5% YoY); reaffirms FY2025 guidance; Evolysse launch strong
--------------------------------------------------------------------------------

- Q1 global net revenue $68.5M, up 15.5% from Q1 2024 on higher volumes and market share gains.
- GAAP operating loss $15.2M; non-GAAP operating loss $5.5M (excludes stock-based comp, depreciation).
- Reaffirmed FY2025 revenue guidance $345M to $355M, representing 30-33% growth over 2024.
- Evolysse HA filler launched April 2025; strong early adoption; expected 8-10% of 2025 revenue.
- On track for positive non-GAAP operating income in Q4 2025 and full-year 2025; tariffs no impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056225000074/0001570562-25-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056225000074/eols-20250507.htm
  HTML page:      https://secwatch.observer/filing/0001570562-25-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer